Perspective Therapeutics (CATX) FCF Margin Growth (1y) (2011 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -80.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 473.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 23.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -431.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -1,716.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2,811.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2,833.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 192.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 261.00
10 Perspective Therapeutics 380.23 Mn 380.23 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 -39,894.00
Jun 30, 2023 -34,845.00
Mar 31, 2023 -49,247.00
Sep 30, 2022 -2,454.00
Mar 31, 2022 -2,237.00
Dec 31, 2021 13,302.00
Sep 30, 2021 -6,447.00
Mar 31, 2021 400.00
Dec 31, 2020 2,798.00
Sep 30, 2020 1,352.00
Jun 30, 2020 1,762.00
Mar 31, 2020 4,474.00
Dec 31, 2019 160.00
Sep 30, 2019 7,806.00
Jun 30, 2019 4,102.00
Mar 31, 2019 -239.00
Dec 31, 2018 4,107.00
Sep 30, 2018 3,112.00
Jun 30, 2018 1,028.00
Mar 31, 2018 4,624.00
Dec 31, 2017 6,512.00
Sep 30, 2017 -286.00
Jun 30, 2017 3,644.00
Mar 31, 2017 -3,816.00
Dec 31, 2016 -9,971.00
Sep 30, 2016 -5,050.00
Jun 30, 2016 -9,671.00
Mar 31, 2016 1,863.00
Jun 30, 2015 5,749.00
Mar 31, 2015 -5,617.00
Jun 30, 2014 -4,114.00
Mar 31, 2014 1,613.00
Dec 31, 2013 -2,020.00
Sep 30, 2013 371.00
Jun 30, 2013 -1,355.00
Mar 31, 2013 161.00
Dec 31, 2012 -1,955.00
Sep 30, 2012 -4,363.00
Jun 30, 2012 140.00
Mar 31, 2012 -2,005.00
Dec 31, 2011 1,517.00
Sep 30, 2011 315.00